The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories
暂无分享,去创建一个
Abbas M. Hassan | Vijay Kumar Chattu | Stephen S. Lim | T. Vos | D. Calina | S. Hay | C. la Vecchia | T. Meretoja | N. Bhala | V. Chattu | Sheng-Chia Chung | M. Dirac | Shirin Djalalinia | F. Farzadfar | F. Fischer | J. Jonas | J. Jozwiak | J. Lazarus | L. Lim | S. Lorkowski | T. Meštrović | E. Mirrakhimov | A. Misganaw | A. Mokdad | I. Oh | A. Pourshams | L. Roever | G. Roshandel | A. Sahebkar | A. Samy | J. Soriano | T. Vasankari | Chuanhua Yu | B. Larijani | S. Tharwat | H. Harapan | J. Schattenberg | V. Podder | A. Mohammadian-Hafshejani | A. Biondi | A. Mentis | S. Bolla | Aaminah Ahmad | S. Safi | Vikrant Gupta | N. Wickramasinghe | Saeid Bitaraf | A. Bhagavathula | M. Keykhaei | B. Tigabu | A. Elsharkawy | A. Ahmadi | S. Ezzikouri | M. Vacante | Mohammad-Salar Hosseini | Z. Natto | S. E. Ibitoye | H. Patel | M. Golechha | Hubert Amu | Pradhum Ram | Deepa Dongarwar | S. Sankararaman | S. Shorofi | Md Shahjahan Siraj | Junjie. Huang | N. Ismail | Ginenus Fekadu | R. Valizadeh | Gayatri Pemmasani | B. Oancea | U. Jayarajah | Rami S. Kantar | A. H. Ali | Moien A B Khan | E. Murillo-Zamora | I. Karaye | Jamal Majidpoor | V. C. Hsieh | S. Alqahtani | I. El Sayed | S. Zelber-Sagi | Pouya Goleij | Hannah Han | M. D. Naimzada | V. Núñez-Samudio | J. Padubidri | Eman Abu-Gharbieh | N. Rezaei | Sina Rashedi | O. Oladunjoye | Parnian Shobeiri | O. Dadras | Maryam Hashemian | S. Jayaram | Sahar Masoudi | U. Saeed | S. Sahoo | M. Abbasi-Kangevari | Zhi-Jiang Zhang | S. Bagherieh | E. George | J. Kauppila | T. Ekundayo | Chun-Han Lo | R. Niazi | M. Bardhan | Ali Shamekh | O. Abu-Shawer | Amir Anoushiravani | A. Sohrabpour | M. Alkhayyat | Mohamed A Elmonem | V. Patthipati | N. Kapoor | Reza Homayounfar | Sami A. Almustanyir | Alia Kabir | A. Skryabina | E. Jamshidi | Ismael Campos-Nonato | N. Baghcheghi | M. Zangiabadian | Ker-Kan Tan | H. Koohestani | S. Hoveidamanesh | S. Azadnajafabad | Mohammad-Reza Malekpour | Amit Goel | N. Elemam | T. Ashraf | T. Kanko | I. Rao | S. Perna | M. Salehi | Keita Suzuki | C. Murray | H. Nassereldine | Sanam Hariri | Sang-Woong Lee | Miquel Martorell | M. Rashidi | B. Saberzadeh-Ardestani | Allen Seylani | Elaheh Shaker | M. Taheri | Cong Wang | M. Zahir | M. Aggarwal | Bantalem Tilaye Atinafu | A. Olivas-Martínez | Haneil Larson Dsouza | D. Ramírez | Yuta Hiraike | Trenton M. White | Amirali Aali | A. N. Bhat | J. A. B. Rodriguez | Paramdeep Singh | Nikhil Kenny Thomas | D. Satti | Abel Joseph | S. Hamid | Suowen Xu | Sandra Cortés | M. Nour | A. Kuttikkattu | Y. Mansoori | R. Patnaik | H. Mark | O S Ilesanmi | Akila Prashant | Ismaeel Yunusa | Amr Farwati | F. Alahdab | Jasvinder A. Singh | J. Muhammad | Abel Joseph | Song Wang | Omar B. Da’ar | Pritik A. Shah | Min Seo Kim | B. Ahinkorah | D. Contreras | Salman Hussain | Linda Merin J | S. Rashedi | Sedighe Hosseini Shabanan | Yeong Yeh Lee | B. Danaei | Mohammed Bheser Hassen | Charity Ehimwenma Joshua | Seyed Mohammad Vahabi | C. C. Iwu | Chinmoy Sarkar | Parham Habibzadeh | A. Boustany | Sreenivas Narasimha Swamy | X. Dai | S. Ghamari | Mariah Malak Bilalaga | Rupak Desai | Tushar Garg | Bijay Mukesh Jeswani | Vidya Kadashetti | Beng Seoyeon Park | Soodabeh Hoveidamanesh | M. Elmonem | Mahaveer Golechha | Mainak Bardhan | Iman El Sayed | Yuta Hiraike | Bantalem Tilaye Tilaye Atinafu | Moien A. B. Khan
[1] F. Underwood,et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. , 2022, The lancet. Gastroenterology & hepatology.
[2] J. Lazarus,et al. The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas. , 2022, The lancet. Gastroenterology & hepatology.
[3] M. Beutel,et al. Prevalence and Risk Factors of Advanced Liver Fibrosis in a Population‐Based Study in Germany , 2022, Hepatology communications.
[4] R. Malekzadeh,et al. The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge? , 2021, Journal of hepatology.
[5] Myeong Jun Song,et al. Advancing the global public health agenda for NAFLD: a consensus statement , 2021, Nature Reviews Gastroenterology & Hepatology.
[6] N. Gouveia,et al. Latin American cities with higher socioeconomic status are greening from a lower baseline: evidence from the SALURBAL project , 2021, Environmental research letters : ERL [Web site].
[7] F. Tacke,et al. A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach , 2021, medRxiv.
[8] V. Wong,et al. Defining comprehensive models of care for NAFLD , 2021, Nature Reviews Gastroenterology & Hepatology.
[9] Suyoung Kim,et al. Prevalence of liver fibrosis and associated risk factors in the Korean general population: a retrospective cross-sectional study , 2021, BMJ Open.
[10] V. de Lédinghen,et al. Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis , 2021, Liver international : official journal of the International Association for the Study of the Liver.
[11] J. Ralston,et al. Obesity, SDGs and ROOTS: a Framework for Impact , 2021, Current Obesity Reports.
[12] Meeyoung Cha,et al. Urban green space and happiness in developed countries , 2021, EPJ Data Sci..
[13] H. El‐Serag,et al. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention , 2020, Nature Reviews Gastroenterology & Hepatology.
[14] Dan J Stein,et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.
[15] O. Hamdy,et al. Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand? , 2020, Clinical Diabetes and Endocrinology.
[16] C. Stave,et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. , 2020, The lancet. Gastroenterology & hepatology.
[17] H. Sadatsafavi,et al. The Impact of Green Space on Violent Crime in Urban Environments: An Evidence Synthesis , 2019, International journal of environmental research and public health.
[18] A. Plasència,et al. Urban health: an example of a “health in all policies” approach in the context of SDGs implementation , 2019, Globalization and health.
[19] Kazuhito Ichii,et al. Improved Characterisation of Vegetation and Land Surface Seasonal Dynamics in Central Japan with Himawari-8 Hypertemporal Data , 2019, Scientific Reports.
[20] J. Bigna,et al. The rising burden of non-communicable diseases in sub-Saharan Africa. , 2019, The Lancet. Global health.
[21] P. Galle,et al. Health-related Quality of Life in Non-alcoholic Fatty Liver Disease Associates With Hepatic Inflammation. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[22] F. Tacke,et al. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis , 2019, Hepatology.
[23] V. Wong,et al. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[24] Viniece Jennings,et al. The Relationship between Social Cohesion and Urban Green Space: An Avenue for Health Promotion , 2019, International journal of environmental research and public health.
[25] S. Asch,et al. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease. , 2018, Gastroenterology.
[26] Reza Ghadimi. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, Lancet.
[27] K. Rasanathan,et al. Governing multisectoral action for health in low-income and middle-income countries: unpacking the problem and rising to the challenge , 2018, BMJ Global Health.
[28] N. Sattar,et al. Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease , 2018, BMC Medicine.
[29] M. Petticrew,et al. The need for a complex systems model of evidence for public health , 2017, The Lancet.
[30] Rohit Loomba,et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease , 2017, Hepatology.
[31] Manuel Romero-Gómez,et al. Treatment of NAFLD with diet, physical activity and exercise. , 2017, Journal of hepatology.
[32] T. Card,et al. Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review. , 2017, The lancet. Gastroenterology & hepatology.
[33] E. Bugianesi,et al. Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers , 2016, International journal of molecular sciences.
[34] Z. Wang,et al. Obesity is an independent risk factor for non‐alcoholic fatty liver disease: evidence from a meta‐analysis of 21 cohort studies , 2016, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[35] D. Lawlor,et al. The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis , 2015, PloS one.
[36] O. Franco,et al. The global impact of non-communicable diseases on macro-economic productivity: a systematic review , 2015, European Journal of Epidemiology.
[37] Peter S Hill,et al. How can health remain central post-2015 in a sustainable development paradigm? , 2014, Globalization and Health.
[38] Vishal Ghevariya,et al. Knowing What’s Out There: Awareness of Non-Alcoholic Fatty Liver Disease , 2014, Front. Med..
[39] D. Evans,et al. The financial burden from non-communicable diseases in low- and middle-income countries: a literature review , 2013, Health Research Policy and Systems.
[40] G. Targher,et al. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis , 2013, Nature Reviews Gastroenterology &Hepatology.
[41] Jeffrey B. Schwimmer,et al. Prevalence of Fatty Liver in Children and Adolescents , 2006, Pediatrics.
[42] SDG Indicators , 2021, Encyclopedia of the UN Sustainable Development Goals.
[43] Xiaoxi Li. Transforming Our World: The 2030 Agenda for Sustainable Development: An Appeal of Global Cooperation for Building Green Civilization , 2020, Green Civilization.
[44] N. Kabisch. The Influence of Socio-economic and Socio-demographic Factors in the Association Between Urban Green Space and Health , 2019, Biodiversity and Health in the Face of Climate Change.
[45] N. Çelik,et al. Fatty liver disease in an autopsy series of children and adolescents. , 2012, Hippokratia.